Safety Study of an Oral Vaccine to Prevent Seasonal Influenza

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

VXA-A1.1 Oral Vaccine

One or two doses of replication incompetent adenovirus oral tablet vaccine

BIOLOGICAL

VXA Placebo Tablet

Off-white tablets similarly formulated to the active drug product tablets.

Trial Locations (1)

90630

WCCT, Cypress

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vaxart

INDUSTRY

NCT01688297 - Safety Study of an Oral Vaccine to Prevent Seasonal Influenza | Biotech Hunter | Biotech Hunter